The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013114 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Diprasom Das und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America. Hauptthemen laut MEDLINE: Interferon-gamma, Candida auris, Skin, Candidiasis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Candida auris is an emerging multidrug-resistant skin-tropic fungal pathogen that causes serious human infections. However, the factors that regulate C. auris skin infection in vivo are still unclear. In this study, we identified that, unlike Candida albicans, which induces IL-17-secreting protective effector Th17 cells, C. auris predominately induces IFNγ-secreting pathogenic Th1 cells during reinfection. Surprisingly, we found that IFNγ enhances skin infection of C. auris but not C. albicans. Mechanistically, IFNγ enhances skin infection of C. auris by dampening the protective IL-17 responses and increasing dermal damage. Furthermore, we identified that the development of Th1 cells occurs through IL-12, produced by C. auris -induced inflammatory macrophages and monocyte-derived dendritic cells. In addition, our findings reveal that C. auris unique cell wall outer mannan layer regulates the development of Th1 and Th17 cells. Collectively, our findings, for the first time, identified that C. auris induces IFNγ to persist in the skin. These findings help explain why C. auris but not C. albicans preferentially persist in the skin long-term, with the potential to identify novel therapeutic approaches to prevent and treat this emerging fungal pathogen in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, United States of America.
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
- Department for Immunology and Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.
- Purdue Institute for Immunology, Inflammation and Infectious Diseases (PI4D), West Lafayette, Indiana, United States of America.
ORCID-Profile: Shankar Thangamani
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Das, D., Ganesh, S. M., Mishra, A., Netea, M. G., & Thangamani, S. (2025). The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013114
Vancouver
Das D, Ganesh SM, Mishra A, Netea MG, Thangamani S. The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013114
BibTeX
@article{Das2025,
author = {Das, Diprasom and Ganesh, Shrihari M and Mishra, Abtar and Netea, Mihai G and Thangamani, Shankar},
title = {The Emerging Fungal Pathogen Candida auris Induces IFNγ to Colonize the Skin},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013114}
}
EUVIMED